Skip to main content
. 2019 Jan 16;8(2):564–571. doi: 10.1002/cam4.1956

Table 2.

Multivariate analyses for progression‐free and overall survival using a Cox proportional hazards model with categorical variables and continuous variables in patients treated with NAC

Variables PFS OS
HR (95% CI) HR (95% CI)
Absolute lymphocyte count (Categorical variablesa)
≥1.49 × 109/L 1 1
<1.49 × 109/L 1.50 (1.07‐2.11) 2.02 (1.21‐3.40)
Absolute lymphocyte count (Continuous variablesb) 0.63 (0.46‐0.88) 0.31 (0.17‐0.56)

ASA, American Society of Anesthesiologists; CI, confidence interval; FIGO, International Federation of Gynecology and Obstetrics; HR, hazard ratio; NAC, neoadjuvant chemotherapy; PFS, progression‐free survival; OS, overall survival.

a

The multivariate analysis was adjusted for categorical variables (age, ASA score, hemoglobin, absolute neutrophil count, CA‐125 level, FIGO stage, histology, residual disease after IDS, chemotherapy regimen, cycles of total chemotherapy).

b

The multivariate analysis was adjusted for continuous variables (age, hemoglobin, absolute neutrophil count, CA‐125 level, cycles of total chemotherapy) and categorical variables (ASA score, FIGO stage, histology, residual disease after IDS, chemotherapy regimen).